Allianz Asset Management’s Vera Therapeutics VERA Stock Holding History

Allianz Asset Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Buy	10,500 +1,800	+21%	+$67.1K	﹤0.01%	2006
2026 Q1	$350K	Hold	8,700	–	–	﹤0.01%	1886
2025 Q4	$441K	Buy	+8,700	New	+$309K	﹤0.01%	1851
2025 Q2	–	Sell	-17,200	Closed	-$413K	–	2313
2025 Q1	$413K	Hold	17,200	–	–	﹤0.01%	1940
2024 Q4	$727K	Hold	17,200	–	–	﹤0.01%	1742
2024 Q3	$760K	Buy	17,200 +1,900	+12%	+$72.1K	﹤0.01%	1726
2024 Q2	$554K	Buy	15,300 +2,200	+17%	+$87.3K	﹤0.01%	1801
2024 Q1	$565K	Buy	+13,100	New	+$467K	﹤0.01%	1581

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Allianz Asset Management's VERA Position: Q2 2026 in Review

Allianz Asset Management increased its Vera Therapeutics (VERA) stake by 21% in Q2 2026, buying an estimated $67.1K and bringing the position to 10,500 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Allianz Asset Management first reported a position in VERA in Q1 2024 and has held it in 8 quarters since. The position peaked at $760K in Q3 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Allianz Asset Management held 10,500 shares of Vera Therapeutics worth $451K as of Q2 2026.
Allianz Asset Management bought 1,800 Vera Therapeutics shares in Q2 2026, an estimated $67.1K.
Vera Therapeutics made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #2006 holding.
Allianz Asset Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 8 quarters since.
Allianz Asset Management's Vera Therapeutics position peaked at $760K in Q3 2024.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.